These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10501566)

  • 21. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.
    Späth M; Pavenstädt H; Petersen J; Schollmeyer P
    Kidney Blood Press Res; 1996; 19(2):81-6. PubMed ID: 8871886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.
    Maeda Y; Han JS; Gibson CC; Knepper MA
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F15-25. PubMed ID: 8393622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of salt-loading on supraoptic vasopressin neurones assessed by ClopHensorN chloride imaging.
    Balapattabi K; Farmer GE; Knapp BA; Little JT; Bachelor M; Yuan JP; Cunningham JT
    J Neuroendocrinol; 2019 Aug; 31(8):e12752. PubMed ID: 31136029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular calcium increase and somatodendritic vasopressin release by vasopressin receptor agonists in the rat supraoptic nucleus: involvement of multiple intracellular transduction signals.
    Sabatier N; Shibuya I; Dayanithi G
    J Neuroendocrinol; 2004 Mar; 16(3):221-36. PubMed ID: 15049853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
    Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of vasopressin receptors in cultured cells derived from the region of rat brain circumventricular organs.
    Jurzak M; Müller AR; Gerstberger R
    Neuroscience; 1995 Apr; 65(4):1145-59. PubMed ID: 7617168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PACAP increases the cytosolic Ca2+ concentration and stimulates somatodendritic vasopressin release in rat supraoptic neurons.
    Shibuya I; Noguchi J; Tanaka K; Harayama N; Inoue U; Kabashima N; Ueta Y; Hattori Y; Yamashita H
    J Neuroendocrinol; 1998 Jan; 10(1):31-42. PubMed ID: 9510056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists.
    Goncharevskaya OA; Shakhmatova EI; Natochin YV
    Pflugers Arch; 1995 Oct; 430(6):1004-11. PubMed ID: 8594534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
    Serradeil-Le Gal C; Wagnon J; Garcia C; Lacour C; Guiraudou P; Christophe B; Villanova G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1993 Jul; 92(1):224-31. PubMed ID: 8392086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular pathways of V(1) and V(2) receptors activated by arginine vasopressin in rat hippocampal neurons.
    Omura T; Nabekura J; Akaike N
    J Biol Chem; 1999 Nov; 274(46):32762-70. PubMed ID: 10551836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Miura I; Inada K; Abe K; Matsumoto Y; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2003 Mar; 44(4):541-52. PubMed ID: 12646291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte.
    Tahara A; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Cardiovasc Res; 1998 Apr; 38(1):198-205. PubMed ID: 9683922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mutual regulation of arginine-vasopressin and PTHrP secretion in dissociated supraoptic neurons.
    Yamamoto S; Morimoto I; Tanaka Y; Yanagihara N; Eto S
    Endocrinology; 2002 Apr; 143(4):1521-9. PubMed ID: 11897711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
    Chen YL; Shepherd C; Spinelli W; Lai FM
    Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft.
    Liu JJ; Chen JR; Buxton BB; Johnston CI; Burrell LM
    Clin Sci (Lond); 1995 Nov; 89(5):481-5. PubMed ID: 8549062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
    Weber R; Pechère-Bertschi A; Hayoz D; Gerc V; Brouard R; Lahmy JP; Brunner HR; Burnier M
    Hypertension; 1997 Nov; 30(5):1121-7. PubMed ID: 9369265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine increases cytosolic Ca2+ in vasopressin neurons.
    Shioda S; Yada T; Muroya S; Takigawa M; Nakai Y
    Neurosci Res; 1997 Dec; 29(4):311-8. PubMed ID: 9527622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.